Spine: A Non-vertebral: B Hip: B
In addition to the evidence that cyclic etidronate reduces vertebral fracture rate in postmenopausal women, data from the GP research database in 7,977 patients on cyclic etidronate and 7.977 age/sex matched controls reported a reduction in non-vertebral fracture by 20% and hip fracture by 34%.
Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.